Citius Oncology (CTOR) Restructuring Costs (2023 - 2026)

Citius Oncology's Restructuring Costs history runs 4 years deep, the most recent figure standing at $567937.0 for Q1 2026.

• In Q1 2026, Restructuring Costs changed 0.0% year-over-year to $567937.0; the TTM figure through Mar 2026 stood at $2.1 million (up 4.29% YoY), while the FY2025 annual figure was $2.2 million, up 19.26% from the prior year.
• Restructuring Costs was $567937.0 for Q1 2026 at Citius Oncology, up from $497937.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $567937.0 in Q4 2024 to a low of $30000.0 in Q1 2023.
• Historically, Restructuring Costs has averaged $390665.0 across 4 years, with a median of $486309.5 in 2024.
• The sharpest annual moves came in 2024 and 2025: Restructuring Costs soared 1482.29% in 2024, then fell 12.33% in 2025.
• A 4-year view of Restructuring Costs shows it stood at $422282.0 in 2023, then jumped by 34.49% to $567937.0 in 2024, then fell by 12.33% to $497937.0 in 2025, then gained by 14.06% to $567937.0 in 2026.
• The last three Restructuring Costs figures came in at $567937.0 (Q1 2026), $497937.0 (Q4 2025), and $497931.0 (Q3 2025), per Business Quant data.